- Home
- SRG vs APYX Comparison
SRG vs APYX Comparison
Compare SRG & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRG | APYX |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | United States | United States |
| Employees | N/A | 220 |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.5M | 164.5M |
| IPO Year | 2015 | 1987 |
Fundamental Metrics
Financial Performance| Metric | SRG | APYX |
|---|---|---|
| Price | $3.26 | $4.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 170.0K | 132.7K |
| Earning Date | 11-14-2025 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $17,406,000.00 | ★ $47,902,000.00 |
| Revenue This Year | N/A | $9.36 |
| Revenue Next Year | N/A | $6.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.43 | $0.76 |
| 52 Week High | $4.56 | $4.44 |
Technical Indicators
Market Signals| Indicator | SRG | APYX |
|---|---|---|
| Relative Strength Index (RSI) | 38.14 | 56.09 |
| Support Level | $3.31 | $3.76 |
| Resistance Level | $3.89 | $4.15 |
| Average True Range (ATR) | 0.14 | 0.25 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 3.08 | 70.48 |
Price Performance
Historical ComparisonAbout SRG Seritage Growth Properties
Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, and leasing of diversified and mixed-use properties throughout the United States.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.